Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel (ALCOOTAX)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Chemotherapy with docetaxel or paclitaxel on an every 3-week schedule.
Patient with bitherapy are eligible only if the taxane is the first infusion.
All type of tumor.
Age>18 years old.
Signed written informed consent.
Patient under 18.
Patient with bitherapy, if docetaxel or paclitaxel is not administered first.